Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine

Ellen E. Sparger, Robert A. Dubie, Barbara Shacklett, Kelly S. Cole, W. L. Chang, Paul A Luciw

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Studies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human immunodeficiency virus (SHIV) have demonstrated that live-attenuated viral vaccines are highly effective; however these vaccine viruses maintain a low level of pathogenicity. Lentivirus attenuation associated with deletion of the viral vif gene carries a significantly reduced risk for pathogenicity, while retaining the potential for virus replication of low magnitude in the host. This report describes a vif-deleted simian immunodeficiency virus (SIV)mac239 provirus that was tested as an attenuated proviral DNA vaccine by inoculation of female rhesus macaques. SIV-specific interferon-γ enzyme-linked immunospot responses of low magnitude were observed after immunization with plasmid containing the vif-deleted SIV provirus. However, vaccinated animals displayed strong sustained virus-specific T cell proliferative responses and increasing antiviral antibody titers. These immune responses suggested either persistent vaccine plasmid expression or low level replication of vif-deleted SIV in the host. Immunized and unvaccinated macaques received a single high dose vaginal challenge with pathogenic SIVmac251. A transient suppression of challenge virus load and a greater median survival time was observed for vaccinated animals. However, virus loads for vaccinated and unvaccinated macaques were comparable by twenty weeks after challenge and overall survival curves for the two groups were not significantly different. Thus, a vif-deleted SIVmac239 proviral DNA vaccine is immunogenic and capable of inducing a transient suppression of pathogenic challenge virus, despite severe attenuation of the vaccine virus.

Original languageEnglish (US)
Pages (from-to)261-272
Number of pages12
JournalVirology
Volume374
Issue number2
DOIs
StatePublished - May 10 2008

Fingerprint

Simian Immunodeficiency Virus
DNA Vaccines
Macaca mulatta
Vaccination
Viruses
Proviruses
Vaccines
Macaca
Virulence
Plasmids
vif Genes
Viral Vaccines
Lentivirus
Attenuated Vaccines
Viral Genes
Virus Replication
Interferons
Primates
Antiviral Agents
Immunization

Keywords

  • DNA vaccine
  • Immunogenicity
  • SIV
  • vif

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine. / Sparger, Ellen E.; Dubie, Robert A.; Shacklett, Barbara; Cole, Kelly S.; Chang, W. L.; Luciw, Paul A.

In: Virology, Vol. 374, No. 2, 10.05.2008, p. 261-272.

Research output: Contribution to journalArticle

Sparger, Ellen E. ; Dubie, Robert A. ; Shacklett, Barbara ; Cole, Kelly S. ; Chang, W. L. ; Luciw, Paul A. / Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine. In: Virology. 2008 ; Vol. 374, No. 2. pp. 261-272.
@article{449044247eff43a3a14f3046f732d891,
title = "Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine",
abstract = "Studies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human immunodeficiency virus (SHIV) have demonstrated that live-attenuated viral vaccines are highly effective; however these vaccine viruses maintain a low level of pathogenicity. Lentivirus attenuation associated with deletion of the viral vif gene carries a significantly reduced risk for pathogenicity, while retaining the potential for virus replication of low magnitude in the host. This report describes a vif-deleted simian immunodeficiency virus (SIV)mac239 provirus that was tested as an attenuated proviral DNA vaccine by inoculation of female rhesus macaques. SIV-specific interferon-γ enzyme-linked immunospot responses of low magnitude were observed after immunization with plasmid containing the vif-deleted SIV provirus. However, vaccinated animals displayed strong sustained virus-specific T cell proliferative responses and increasing antiviral antibody titers. These immune responses suggested either persistent vaccine plasmid expression or low level replication of vif-deleted SIV in the host. Immunized and unvaccinated macaques received a single high dose vaginal challenge with pathogenic SIVmac251. A transient suppression of challenge virus load and a greater median survival time was observed for vaccinated animals. However, virus loads for vaccinated and unvaccinated macaques were comparable by twenty weeks after challenge and overall survival curves for the two groups were not significantly different. Thus, a vif-deleted SIVmac239 proviral DNA vaccine is immunogenic and capable of inducing a transient suppression of pathogenic challenge virus, despite severe attenuation of the vaccine virus.",
keywords = "DNA vaccine, Immunogenicity, SIV, vif",
author = "Sparger, {Ellen E.} and Dubie, {Robert A.} and Barbara Shacklett and Cole, {Kelly S.} and Chang, {W. L.} and Luciw, {Paul A}",
year = "2008",
month = "5",
day = "10",
doi = "10.1016/j.virol.2008.01.020",
language = "English (US)",
volume = "374",
pages = "261--272",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine

AU - Sparger, Ellen E.

AU - Dubie, Robert A.

AU - Shacklett, Barbara

AU - Cole, Kelly S.

AU - Chang, W. L.

AU - Luciw, Paul A

PY - 2008/5/10

Y1 - 2008/5/10

N2 - Studies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human immunodeficiency virus (SHIV) have demonstrated that live-attenuated viral vaccines are highly effective; however these vaccine viruses maintain a low level of pathogenicity. Lentivirus attenuation associated with deletion of the viral vif gene carries a significantly reduced risk for pathogenicity, while retaining the potential for virus replication of low magnitude in the host. This report describes a vif-deleted simian immunodeficiency virus (SIV)mac239 provirus that was tested as an attenuated proviral DNA vaccine by inoculation of female rhesus macaques. SIV-specific interferon-γ enzyme-linked immunospot responses of low magnitude were observed after immunization with plasmid containing the vif-deleted SIV provirus. However, vaccinated animals displayed strong sustained virus-specific T cell proliferative responses and increasing antiviral antibody titers. These immune responses suggested either persistent vaccine plasmid expression or low level replication of vif-deleted SIV in the host. Immunized and unvaccinated macaques received a single high dose vaginal challenge with pathogenic SIVmac251. A transient suppression of challenge virus load and a greater median survival time was observed for vaccinated animals. However, virus loads for vaccinated and unvaccinated macaques were comparable by twenty weeks after challenge and overall survival curves for the two groups were not significantly different. Thus, a vif-deleted SIVmac239 proviral DNA vaccine is immunogenic and capable of inducing a transient suppression of pathogenic challenge virus, despite severe attenuation of the vaccine virus.

AB - Studies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human immunodeficiency virus (SHIV) have demonstrated that live-attenuated viral vaccines are highly effective; however these vaccine viruses maintain a low level of pathogenicity. Lentivirus attenuation associated with deletion of the viral vif gene carries a significantly reduced risk for pathogenicity, while retaining the potential for virus replication of low magnitude in the host. This report describes a vif-deleted simian immunodeficiency virus (SIV)mac239 provirus that was tested as an attenuated proviral DNA vaccine by inoculation of female rhesus macaques. SIV-specific interferon-γ enzyme-linked immunospot responses of low magnitude were observed after immunization with plasmid containing the vif-deleted SIV provirus. However, vaccinated animals displayed strong sustained virus-specific T cell proliferative responses and increasing antiviral antibody titers. These immune responses suggested either persistent vaccine plasmid expression or low level replication of vif-deleted SIV in the host. Immunized and unvaccinated macaques received a single high dose vaginal challenge with pathogenic SIVmac251. A transient suppression of challenge virus load and a greater median survival time was observed for vaccinated animals. However, virus loads for vaccinated and unvaccinated macaques were comparable by twenty weeks after challenge and overall survival curves for the two groups were not significantly different. Thus, a vif-deleted SIVmac239 proviral DNA vaccine is immunogenic and capable of inducing a transient suppression of pathogenic challenge virus, despite severe attenuation of the vaccine virus.

KW - DNA vaccine

KW - Immunogenicity

KW - SIV

KW - vif

UR - http://www.scopus.com/inward/record.url?scp=42749094185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749094185&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2008.01.020

DO - 10.1016/j.virol.2008.01.020

M3 - Article

C2 - 18261756

AN - SCOPUS:42749094185

VL - 374

SP - 261

EP - 272

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -